Making sure that patients have access to the medicines they need is - or should be - the top priority of any modern healthcare system. But recent government steps in Turkey will likely prevent patients from getting access to critical medicines. There, the government has discontinued its long-standing process of accepting Good Manufacturing Practice certificates
(GMP) issued by foreign (ex-Turkey) regulatory agencies like the U.S. Food and Drug Administration (FDA)
"We also fear that this new regulation is being implemented in a manner which would block most imported medicines thereby denying patient access to promising new treatments. To the extent the new regulation is intended to protect the health of Turkey's citizens, we believe that the result could be self-defeating."